Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Completed · Phase 2 · Has a placebo group

Conditions studied: Sexual Dysfunction, Physiological

In brief

This randomized, double-blind, placebo-controlled clinical trial investigated the effect of once daily oral administration of 20 mg estetrol monohydrate tablet for 12 weeks in postmenopausal women who experienced sexual arousal disorder. Specifically, the main aim was to evaluate whether estetrol (E4) is effective in the treatment of female sexual arousal disorder (FSAD) in women after their menopause.

Key facts

Study ID
NCT06308614
Run by
Estetra
People needed
82
Starts
2024-01-29
Expected to finish
2025-04-21
Last updated by the study team
2026-07-06

Who can join

Age: 40 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.